{"id":165750,"name":"UNITED STATES PHARMACOPEIAL CONVENTION (USP)","slug":"united-states-pharmacopeial-convention-usp","state":"MD","country":"United States of America","description":"Pharmaceutical quality setting organization","totalSpending":730000,"filings":16,"yearlySpending":[{"year":2019,"income":130000},{"year":2020,"income":280000},{"year":2021,"income":200000},{"year":2022,"income":120000}],"issues":["HCR"],"firms":["CAPITOL HILL CONSULTING GROUP"],"lobbyists":["BRIAN SUTTER","THOMAS WHARTON","EMILY WILKINSON-HOLLAND","DAVID JORY"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","Food & Drug Administration (FDA)"],"sampleDescriptions":["Maintaining US support for quality standards.","Maintaining US support for quality standards.","Maintaining US support for quality pharmaceutical standards.","Maintaining US support for quality pharmaceutical standards.","Maintaining US support for quality pharmaceutical standards. Issues related to coronavirus, including drug and supply chain safety."],"years":[2019,2020,2021,2022]}